| 臺大學術典藏 |
2020-02-12T05:48:24Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H; Hung C.-S; Liao C.-W; LING-HUNG WEI; Chen C.-W; Shun C.-T; Wen W.-F; Wan C.-H; Wu X.-M; Chang Y.-Y; Wu V.-C; Wu K.-D; Lin Y.-H. |
| 臺大學術典藏 |
2020-12-18T05:20:40Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
YEN-HUNG LIN; Wu K.-D.; Chou C.-H.; Hung C.-S.; Liao C.-W.; Wei L.-H.; Chen C.-W.; Shun C.-T.; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C. |
| 臺大學術典藏 |
2021-03-18T02:02:26Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H.;Hung C.-S.;Liao C.-W.;Wei L.-H.;Chen C.-W.;Chia-Tung Shun;Wen W.-F.;Wan C.-H.;Wu X.-M.;Chang Y.-Y.;Wu V.-C.;Wu K.-D.;Lin Y.-H.; Chou C.-H.; Hung C.-S.; Liao C.-W.; Wei L.-H.; Chen C.-W.; CHIA-TUNG SHUN; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2021-11-04T08:48:12Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H.; Hung C.-S.; CHE-WEI LIAO; Wei L.-H.; Chen C.-W.; Shun C.-T.; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; Wu V.-C.; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2021-11-30T04:53:42Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou C.-H.; Hung C.-S.; Liao C.-W.; Wei L.-H.; Chen C.-W.; Shun C.-T.; Wen W.-F.; Wan C.-H.; Wu X.-M.; Chang Y.-Y.; VIN-CENT WU; Wu K.-D.; Lin Y.-H. |
| 臺大學術典藏 |
2022-09-08T02:21:50Z |
IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis
|
Chou, Chia-Hung; Hung, Chi-Sheng; Liao, Che-Wei; LING-HUNG WEI; CHING-WAY CHEN; Shun, Chia-Tung; Wen, Wen-Fen; Wan, Cho-Hua; Wu, Xue-Ming; Chang, Yi-Yao; Wu, Vin-Cent; Wu, Kwan-Dun; Lin, Yen-Hung |
| 國立臺灣大學 |
2009 |
IL-6 經由Smad恢復TGF-beta對樹狀細胞成熟的抑制
|
陳墨繁; Chen, Mo-Fan |
| 國立臺灣大學 |
2015 |
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
|
Kao, Jung-Ta; Feng, Chun-Lung; Yu, Cheng-Ju; Tsai, Shu-Mei; Hsu, Ping-Ning; Chen, Yao-Li; Wu, Yi-Ying; 許秉寧 |
| 臺大學術典藏 |
2021-02-02T02:47:59Z |
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: A cohort study
|
Kao J.-T.; Feng C.-L.; Yu C.-J.; Tsai S.-M.; PING-NING HSU; Chen Y.-L.; Wu Y.-Y. |
| 國立臺灣大學 |
2007 |
Il-6-Encoding Tumor Antigen Generates Potent Cancer Immunotherapy through Antigen Processing and Anti-Apoptotic Pathways
|
謝長堯; 陳祈安; 黃家彥; 張明正; 李建南; 蘇怡寧; 鄭文芳; HSIEH, CHANG-YAO; CHEN, CHI-AN; HUANG, CHIA-YEN; CHANG, MING-CHENG; LEE, CHIEN-NAN; SU, YI-NING; CHENG, WEN-FANG |
| 臺大學術典藏 |
2007 |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
CHIEN-NAN LEE; WEN-FANG CHENG; CHI-AN CHEN; Hsieh, C.-Y. and Chen, C.-A. and Huang, C.-Y. and Chang, M.-C. and Lee, C.-N. and Su, Y.-N. and Cheng, W.-F. |
| 臺大學術典藏 |
2020-01-22T07:50:45Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Cheng W.-F.; Su Y.-N.; Lee C.-N.; Chang M.-C.; Huang C.-Y.; CHI-AN CHEN; Hsieh C.-Y.; Hsieh C.-Y.;Chi-An Chen;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Cheng W.-F. |
| 臺大學術典藏 |
2020-02-06T05:22:23Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
WEN-FANG CHENG;Su Y.-N.;Lee C.-N.;Chang M.-C.;Huang C.-Y.;Chen C.-A.;Hsieh C.-Y.; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-12T04:06:10Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Cheng W.-F.;Su Y.-N;CHIEN-NAN LEE;Chang M.-C;Huang C.-Y;Chen C.-A;Hsieh C.-Y; Hsieh C.-Y; Chen C.-A; Huang C.-Y; Chang M.-C; CHIEN-NAN LEE; Su Y.-N; Cheng W.-F. |
| 臺大學術典藏 |
2020-02-14T02:50:06Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Hsieh C.-Y.;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Wen-Fang Cheng; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-11-27T08:14:25Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Chang-Yao Hsieh;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Cheng W.-F.; CHANG-YAO HSIEH; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; Cheng W.-F. |
| 臺大學術典藏 |
2021-02-04T06:05:02Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Hsieh C.-Y.;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Chien-Nan Lee;Su Y.-N.;Cheng W.-F.; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; CHIEN-NAN LEE; Su Y.-N.; Cheng W.-F. |
| 國立臺灣大學 |
2007-10 |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways.
|
Hsieh, CY; Chen, CA; Huang, CY; Chang, MC; Lee, CN; Su, YN; Cheng, WF |
| 國家衛生研究院 |
2010-06 |
IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth
|
Hsieh, CL;Liu, SJ;Shen, CR;Chen, MY;Hsu, SC;Tsai, JP;Li, YS;Yang, CJ;Chong, P;Chen, HW |
| 中國醫藥大學 |
2010-06 |
IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth
|
謝嘉齡(Chia-Ling Hsieh); 劉士仕(Shih-Jen Liu); 沈家瑞(Chia-Rui Shen); 陳玫瑜(Mei-Yu Chen); 許素菁(Shu-Ching Hsu); 蔡之平(Jy-Ping Tsai); 李宜軒(Yi-Shiuan Li); 楊靜仁(Ching-Jen Yang); 莊再成(Pele Chong); 陳信偉(Hsin-Wei Chen)* |
| 臺北醫學大學 |
2010 |
IL-6刺激人類肺部纖維母細胞結締組織生長因子表現之分子機轉探討
|
蔡睿益 |
| 中國醫藥大學 |
2018-12-04 |
IL-6參與lapatinib引發三陰性乳癌轉移之探討
|
蕭宇君;Yu-Chun Hsiao |
| 國立臺灣大學 |
2016 |
IL-6反式訊息傳遞途徑在放射線導致之肺纖維化中所扮演的角色
|
吳晉睿; Wu, Chin-Jui |
| 元培科技大學 |
2017-11-13 |
IL-6受體抗體在k-ras突變的結腸直腸癌細胞上抑制體內腫瘤生長和血管
|
劉葦君;徐治平;鍾元強 |
| 元培科技大學 |
2020 |
IL-6和VEGF-A信號傳導抑制劑聯合療法對大腸癌細胞的抑制效果
|
葉家銨 |
